<DOC>
	<DOCNO>NCT00043927</DOCNO>
	<brief_summary>This study gather compare data effectiveness safety two different treatment extensive Small Cell Lung Cancer ( SCLC ) patient receive previous chemotherapy . One treatment use investigational drug combination FDA approve chemotherapy . The treatment use combination two FDA approve chemotherapy drug .</brief_summary>
	<brief_title>Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Written inform consent ( patient 's write understanding agreement participate study ) . Patients confirm extensive small cell lung cancer ( SCLC ) . No prior chemotherapy within 5 year diagnosis SCLC . Presence either measurable nonmeasurable SCLC Xray physical examination . At least 3 week since last major surgery ( less period acceptable decide best interest patient ) . At least 24 hour since prior radiotherapy . Patients receive radiotherapy must recover reversible side effect , nausea vomiting . Laboratory criterion : Patients must adequate bone marrow reserve adequate kidney liver function . Symptoms spread disease brain require treatment drug call steroid . Any active infection . Severe medical problem diagnosis SCLC , would limit ability patient follow study guideline would expose patient extreme risk . Ongoing plan chemotherapy , immunotherapy , radiotherapy , investigational therapy treatment SCLC . Use investigational drug within 30 day first dose study medication . Women pregnant lactating . Patients childbearing potential refuse practice adequate form birth control . Patients clinical evidence stomach intestinal ( GI ) condition . Patients require treatment drug cyclosporin A .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Chemotherapy-naive</keyword>
	<keyword>Small Cell Lung Cancer</keyword>
	<keyword>SCLC</keyword>
	<keyword>Extensive disease</keyword>
	<keyword>ED</keyword>
	<keyword>topotecan</keyword>
	<keyword>Hycamtin</keyword>
	<keyword>oral</keyword>
</DOC>